The single most important causative factor for malignant melanomas of the skin is UV radiation. However, this is not true for melanomas on body surfaces sheltered from the sun; thus, it is important to seek new causative factors of melanoma genesis. Human papillomaviruses and gammaherpesviruses are associated with human skin cancer; for example, human papillomavirus types 5 and 8 are associated with epidermodysplasia verruciformis, and human herpesvirus 8 is associated with Kaposi's sarcoma. Recently, a newly described human polyomavirus, Merkel cell polyomavirus (MCPyV), has been associated with Merkel cell carcinoma, an unusual form of neurotropic skin cancer. Moreover, melanocytes are of neuroepithelial origin. This background impelled us to investigate if human polyomavirus DNA could play a role in the development of extracutaneous melanomas. Sixty-four extracutaneous melanomas were initially collected and dissected. Of these, 38 could be successfully used for further testing for the presence of the five human polyomaviruses known so far-BK virus (BKV), JC virus (JCV), KI polyomavirus (KIPyV), WU polyomavirus (WUPyV), and MCPyV-and of simian virus 40 (SV40). No polyomavirus DNA could be detected in any of the samples tested by use of a nested PCR detecting BKV, JCV, and SV40; a newly designed PCR detecting KIPyV and WUPyV; or a newly designed PCR for MCPyV. We conclude that since no human polyomavirus DNA was detected in primary malignant melanomas on non-sun-exposed body surfaces, these polyomaviruses presumably are not major factors for the development of extracutaneous melanomas.
The single most important factor for the development of malignant melanomas of the skin is UV radiation. In addition, numerous other risk factors or cofactors have been demonstrated, such as, e.g., hereditary/familial predisposition, a large number of nevi, the skin phenotype, and the hair and eye colors (13) . However, UV radiation presumably cannot be responsible for some subgroups of cutaneous melanomas on body surfaces more or less sheltered from the sun, such as the acral lentiginous melanomas of the palms, soles, and subungual areas. Moreover, melanomas can appear on body surfaces completely sheltered from the sun, e.g., mucosal membranes of the sinonasal cavity, the anus-rectum, the vulva-vagina, and the penis. These melanomas, sometimes named extracutaneous melanomas, are rare in absolute numbers compared to the cutaneous melanomas but are similar to them if density (i.e., the average number of tumors per square unit of body surface area) is taken into account (19) . This similarity in melanoma density is compelling and demonstrates the necessity of finding new causative factors of melanoma genesis. Nevertheless, there are biological differences between cutaneous and extracutaneous melanomas, and it is possible that by comparing extracutaneous melanomas with cutaneous melanomas, we may find non-UV-light-associated factors or cofactors in melanoma genesis. Viruses could be such factors. It is possible that DNA viruses are associated with melanoma genesis, even if this is extremely difficult to demonstrate. In previous reports, we have investigated whether human papillomavirus (HPV) or any of the eight viruses of the human herpesvirus group were present in more than 40 extracutaneous melanomas. No HPV DNA-positive melanoma was detected, although different general primers and several type-specific primers were used, and only two herpesvirus-positive melanomas were detected, indicating that neither HPV nor viruses of the herpesvirus family are major etiological agents for extracutaneous melanomas (7, 15) .
In the present study, we were particularly interested in exploring the possible presence in extracutaneous melanomas of the five presently known members of the human polyomavirus family and simian virus 40 (SV40), since some of these viruses are potentially neurotropic and melanocytes have a neuroepithelial origin. Since their discovery in 1971, BK virus (BKV) and JC virus (JCV) (10, 18) had been the only known human polyomaviruses; last year, however, two new human viruses, KI polyomavirus (KIPyV) and WU polyomavirus (WUPyV), were identified (2, 11) . In addition, more recently, a fifth human polyomavirus has been identified in several cases of Merkel cell carcinoma, a rare malignancy of the skin; this virus was therefore named Merkel cell polyomavirus (MCPyV) (9) . While KIPyV and WUPyV have not yet been linked to any disease, MCPyV has been suggested to be a contributing factor in the pathogenesis of Merkel cell carcinoma (9) . Polyomaviruses are generally species specific, and as mentioned above, five have been described as human polyomaviruses (23) . However, in addition to these five, a sixth polyomavirus, SV40, from the rhesus monkey, has, to a variable but generally rare extent, been detected in humans (3) . Both BKV and JCV establish latency after primary infection and can be reactivated under certain circumstances (21) . Seroprevalence (in Sweden) ranges from 70 to 80% for both BKV and JCV but is not known for the newly detected human polyomaviruses. However, several studies have found KIPyV, as well as WUPyV, in 1 to 3% of nasopharyngeal aspirates from children (2, 4, 11, 17) . Moreover, in one report, as many as 6% of nasopharyngeal aspirates from healthy children were positive for WUPyV (1) .
In the present study, we aimed to investigate whether human polyomaviruses could be detected in melanomas from nonsun-exposed body areas and whether they could possibly be considered causative agents in the genesis of some melanomas. For this purpose, more than 30 formalin-fixed extracutaneous melanoma samples were examined for the presence of human polyomavirus DNA.
MATERIALS AND METHODS
Patients' tumor material. Thirty-eight mucosal melanoma samples with confirmed PCR-amplifiable DNA tested in two previous studies (7, 15) were selected from samples from 64 patients who were diagnosed from 1985 to 2003 and reported to the (compulsory) Swedish Cancer Registry. The present study was conducted with the permission of the Swedish Data Inspection Authority and the Human Ethical Committee at the Karolinska Institutet and was in compliance with their rules. All histological slides were reviewed, and only primary melanomas, not metastases, were used for further analysis.
Preparation of samples.
One 4-m-thick and two 20-m-thick consecutive sections were cut from each paraffin block of formalin-fixed tissue. The 4-m sections were stained with hematoxylin and eosin to guide the dissection of tumor tissue to be used for DNA analysis. Tumor tissues were dissected with a scalpel under light microscopy in each case in order to avoid potential contamination with virus from surrounding tissues and from heavily inflammatory cell infiltrates. This procedure resulted in approximately 90% pure tumor samples for further analysis. Similarly, microtome knives and scalpels were washed in 70% ethanol between each preparation, and each section was stretched on a drop of distilled water placed on each slide, instead of using a regular water bath, in order to avoid contamination. In seven cases, the whole biopsy specimen contained tumor tissue and further dissection was not necessary. DNA extraction. DNA was extracted using the High Pure RNA extraction kit (Roche Diagnostics GmbH, Mannheim, Germany) according to the manufacturer's protocol, but without DNase treatment. Briefly, the paraffin was removed by treatment with xylene and ethanol. The tissue pellet was disrupted by overnight incubation at 55°C in tissue lysis buffer with the addition of sodium dodecyl sulfate and proteinase K. On day 2, the DNA was bound to a membrane in collection tubes, washed, and eluted by elution buffer. The proteinase K treatment was repeated once (incubation for 1 h at 55°C) for the removal of trace proteins. The DNA was bound to the membrane in a fresh collection tube, washed, and eluted, and finally the DNA amount and purity were measured by NanoDrop technology (NanoDrop Technology Inc., Wilmington, DE). To avoid and check for virus carryover between the melanoma samples, tubes with a slice from an empty paraffin block were placed between the samples and treated in the same way as the melanoma samples throughout the experimental procedures.
Verification of amplifiable DNA. To avoid false-negative results due to DNA unsuitable for PCR analysis, a control PCR with ␤-microglobulin primers was run in 100 to 120 ng DNA for all samples in a previous study (7) .
Nested PCR for the detection of BKV, JCV, and SV40. To detect the presence of BKV, JCV, or SV40, a nested PCR was performed as described previously (5, 12) . In addition, each reaction tube contained 0.4 g/l purified bovine serum albumin (BSA) to avoid possible inhibition of the PCR by a high concentration of melanin in the DNA extracts. A urine sample positive for BKV, used as a positive control, was kindly provided by Anna-Lena Hammarin (SMI, Karolinska Institutet, Stockholm, Sweden).
PCR assay for the detection of KIPyV and WUPyV. To simultaneously detect the presence of KIPyV and WUPyV, a standard PCR was performed with a In addition, each reaction mixture contained 0.4 g/l purified BSA to prevent possible inhibition of the PCR by a high concentration of melanin in the DNA extracts. An initial 1-min denaturation at 94°C was followed by 40 cycles of 30 s at 94°C, 30 s at 53°C, and 45 s at 72°C, which, in turn, were followed by a final step of 5 min at 72°C. To produce a positive control, KIPyV bp 1395 to 2159 was cloned into pBSKS.
PCR assay for the detection of MCPyV. To detect the presence of MCPyV, a standard PCR was performed with a primer pair detecting part of the large T (LT) region of MCPyV ( Table 1 ). The 50-l reaction mixture consisted of 50 mM NaCl, 10 mM Tris-HCl (pH 8. Evaluation of the sensitivities of the KIPyV and WUPyV PCR assay and the MCPyV PCR assay. To define the detection levels of the two newly designed PCR assays for KIPyV, WUPyV, and MCPyV, the assays were performed with increasing concentrations of the respective plasmids, from 5 copies to 1 billion copies. In order to investigate if there was any inhibiting effect of genomic DNA on PCR sensitivity, the detection level was also evaluated with 100 ng, 500 ng, and 1,000 ng of genomic DNA.
RESULTS AND DISCUSSION
To simultaneously assay for the presence of the two related polyomaviruses, KIPyV and WUPyV, a PCR assay utilizing primers directed at identical or nearly identical sequences in the two viruses was established ( Table 1 ). The resulting amplicon had a size of 142 bp, and as few as 10 copies of a plasmid containing the KIPyV VP1 gene could be detected consistently and reliably. The detection limit remained unchanged when genomic DNA was added to the assay (data not shown). In addition, to assay for the presence in melanomas of the early region of MCPyV, a PCR assay utilizing primers detecting the central part of the LT antigen open reading frame was established (Table 1) . This assay generated an amplicon of 138 bp, and 1,000 copies of plasmid pUC57MC1, containing this part of LT, could consistently be detected. The detection level was unaffected when pUC57MC1 was mixed with genomic DNA (data not shown). The two new methods for the detection of KIPyV, WUPyV, and MCPyC were highly sensitive-comparable in sensitivity to the nested PCR for BKV, JCV, and SV40-enabling us to assay for all six polyomaviruses with similar sensitivities.
Sixty-four patients diagnosed with melanomas of the mucous membranes from 1985 to 2003 were initially included in the study. For technical reasons, mainly because of a shortage of tumor tissues in the paraffin blocks, only 38 cases, previously confirmed to have amplifiable DNA (7), were further analyzed for the presence of BKV, JCV, and SV40 DNA. Of these 38 samples, 37 could also be tested for MCPyV and 36 for KIPyV and WUPyV. The sites of these 38 melanomas were as follows: anal canal, 12; anus-rectum, 4; nasal cavity, 6; vulva, 6; vaginacervix, 4; tongue, 1; penis, 1; subungual site, 2; skin, 1; oral cavity, 1. Due to the shortage of some nasal cavity samples, one could not be tested for MCPyV and two others could not be tested for KIPyV and WUPyV. No polyomavirus DNA could be detected in any of the samples by using a nested PCR detecting BKV, JCV, and SV40 or the two newly designed PCR assays, detecting KIPyV and WUPyV or MCPyV, respectively.
To our knowledge, this is the first time the possible presence of polyomaviruses in melanomas was examined, and since melanocytes have a neuroepithelial origin, the possibility was that, e.g., JCV DNA could have been detected in these tumors. Moreover, among the human polyomavirus family, JCV is associated with the growth of glial cells in cases of progressive multifocal leukoencephalopathy. In addition, in several reports, JCV has been detected in a variety of brain tumors, in central nervous system lymphomas, and in colorectal tumors. No causal role of JCV in neoplasia has been established yet (14) . Nonetheless, it is clear that BKV, JCV, and SV40 can cause cancer in laboratory animals (23) , and the report that transgenic mice expressing the SV40 LT antigen in pigment cells can develop melanomas (16) is of specific interest in this context. Furthermore, important steps in neoplastic transformation have been documented for some of the polyomaviruses discussed above, involving the inactivation of p53 and pRb by the binding of the large T antigens of different polyomaviruses to these proteins (6, 8) . Notably, extracutaneous melanomas show a higher frequency of silent mutations in the p53 gene than cutaneous melanomas (20) , which may suggest genomic instability (22) . The hypothesis of genetic instability triggered by the interaction of the large T antigen and p53 led us to consider the role of polyomaviruses in the development of extracutaneous melanomas.
In this study, none of the 38 patient samples tested positive for any of the five human polyomaviruses tested or for SV40, although the methods used in this study had high sensitivity. This argues against the possibility that human polyomaviruses are causative agents of non-UV-light-associated melanomas.
The development of two newly designed PCRs remains interesting for further studies. The regular PCR detecting both KIPyV and WUPyV is highly sensitive and requires less material to test than two distinct PCRs. The regular PCR detecting MCPyV is also highly sensitive and has the advantage of detecting the large T region; thus, it can still detect a truncated virus lacking parts of the late region, which could be the case in the genesis of tumor development.
In conclusion, the present investigation suggests that neither any of the five human polyomaviruses known so far-BKV, JCV, KIPyV, WUPyV, and MCPyV-nor SV40 is involved in the development of extracutaneous melanomas.
